Colan Totte Boosts Sales but Profit Slips, Keeps Full-Year Outlook and Dividend Plan Intact

Colan Totte.Co.,Ltd. ( (JP:7792) ) has shared an announcement.

Colan Totte reported non-consolidated net sales of ¥2.51 billion for the quarter ended 31 December 2025, a robust 32.3% year-on-year increase, but operating profit slipped 1.5% to ¥614 million and ordinary profit fell 3.8% to ¥619 million, with quarterly net profit dropping 19.0% to ¥425 million as margins came under pressure despite strong top-line growth. The company maintained a solid financial position with total assets of ¥7.01 billion and an equity ratio of 74.3%, confirmed that there are no changes to its previously announced full-year forecast calling for 15.6% sales growth but a slight decline in full-year profit, and upheld its dividend policy with a projected annual dividend of ¥44 per share for the fiscal year ending September 30, 2026, signaling continued shareholder returns even amid profit compression.

The most recent analyst rating on (JP:7792) stock is a Buy with a Yen1575.00 price target. To see the full list of analyst forecasts on Colan Totte.Co.,Ltd. stock, see the JP:7792 Stock Forecast page.

More about Colan Totte.Co.,Ltd.

Colan Totte Co., Ltd., listed on the Tokyo Stock Exchange, operates under Japanese GAAP and is engaged in the manufacture and sale of healthcare-related products, including its well-known Colantotte-branded magnetic health gear, primarily targeting the domestic Japanese market.

Average Trading Volume: 14,126

Technical Sentiment Signal: Buy

Current Market Cap: Yen14B

See more insights into 7792 stock on TipRanks’ Stock Analysis page.